About Index Trending news
Analyze
Top 50 Pricing
Promethera Biosciences

Promethera Biosciences

Work at Promethera Biosciences? Add yourself to this profile

Promethera Biosciences

Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.

Elsewhere

Alexa global traffic share

25 Nov 2014
$31,444,456
Venture capital (Series C)
28 Mar 2012
$31,475,320
Venture capital (Series B)
Mitsui & Co. Global Investment, Boehringer Ingelheim Venture Fund, Shire
02 Feb 2010
$7,300,000
Venture capital (Series A)
Life Sciences Partners, Vesalius Biocapital Partners, Société Régionale d'Investissement de Wallonie